Therapy for Autoimmunity

Currently treatments for autoimmune diseases are anti-inflammatory and immunosuppressive, although recent advances in regulatory T cell therapy have shown promise as a potential therapeutic strategy. Discover the latest research on Therapies for Autoimmunity here.

August 10, 2020
Open Access

Mitigating alemtuzumab-associated autoimmunity in MS: A "whack-a-mole" B-cell depletion strategy

Neurology. Neuroimmunology and Neuroinflammation
Ethan MeltzerTeresa C Frohman
August 11, 2020

An evidence based approach to refractory cutaneous lupus erythematosus

Arthritis & Rheumatology
Robert Borucki, Victoria P Werth
August 9, 2020
Open Access

Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview

Frontiers in Immunology
Alessio Romerio, Francesco Peri
July 18, 2020
Open Access

Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)

MedRxiv : the Preprint Server for Health Sciences
C. GruberDusan Bogunovic
July 24, 2020

Targeted and triple therapy-based liposomes for enhanced treatment of rheumatoid arthritis

International Journal of Pharmaceutics
Lingping XueNan Zhang
August 11, 2020
Open Access

Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous rrticaria - A real-life experience

The World Allergy Organization Journal
Ramit Maoz-SegalNancy Agmon-Levin
August 4, 2020

Understanding immune variation for improved translational medicine

Current Opinion in Immunology
Darragh Duffy
July 10, 2020

Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors

Experimental Biology and Medicine
Xin LiPatrick Cy Woo
July 31, 2020

Tacrolimus ameliorates thrombocytopenia in an ITP mouse model

Annals of Hematology
Xiamin WangJianlin Qiao
August 4, 2020

Medical treatment can unintentionally alter the Treg compartment in patients with widespread pathophysiologic conditions

The American Journal of Pathology
Sabrina N CopselRobert B Levy
July 21, 2020

Current and Future molecular mechanism in Inflammation and Arthritis

Journal of Pharmacopuncture
Vikash SharmaRavindra Kumar Pandey
July 17, 2020

Tackling autoimmunity with nanomedicines

Xiangru FengJianxun Ding
July 9, 2020

Adoptive Treg cell-based immunotherapy: Frontier therapeutic aspects in rheumatoid arthritis

Mahdi ZavvarMohammad Hossein Nicknam
August 5, 2020

Utilizzo degli ultrasuoni nelle infezioni da catetere peritoneale: indicazioni e risvolti clinici

Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia
Luca NardelliPiergiorgio Messa
August 10, 2020

Rasmussen's encephalitis: From immune pathogenesis towards targeted-therapy

Seizure : the Journal of the British Epilepsy Association
A OrsiniP Striano
July 14, 2020
Open Access

RNA-Binding Protein ZFP36L2 Downregulates Helios Expression and Suppresses the Function of Regulatory T Cells

Frontiers in Immunology
Sohei MakitaHiroshi Nakajima

Sign up to follow this feed and discover related papers.

Related Feeds

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Adult-Onset Still's Disease

Adult-onset Still's disease (AOSD) is a form of Still's disease, a rare systemic autoinflammatory disease characterized by the classic triad of persistent high spiking fevers, joint pain, and a distinctive salmon-colored bumpy rash. Discover the latest research on AOSD here.

Anti-N-Methyl-D-Aspartate Receptor Encephalitis

Anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis is a form of of brain inflammation due to antibodies against NMDA receptors. Discover the latest research on anti-NMDA receptor encephalitis here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Disease Therapy

In autoimmune diseases, the immune system responds and attacks self-antigens and damages or impairs the function of the tissues. The treatment for autoimmune diseases often involves immunosuppressive agents, but newer treatments are being investigated. Discover the latest research on autoimmune disease therapy here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Autoimmune Hepatitis

Autoimmune hepatitis formerly called lupoid hepatitis, is a chronic, autoimmune disease of the liver that occurs when the body's immune system attacks liver cells causing the liver to be inflamed. Discover the latest research on autoimmune hepatitis here.

© 2020 Meta ULC. All rights reserved